First stereotactic treatment of retino-blastoma using a micro-multileaf collimator
Détails
ID Serval
serval:BIB_753EAF6B4475
Type
Actes de conférence (partie): contribution originale à la littérature scientifique, publiée à l'occasion de conférences scientifiques, dans un ouvrage de compte-rendu (proceedings), ou dans l'édition spéciale d'un journal reconnu (conference proceedings).
Sous-type
Poster: résume de manière illustrée et sur une page unique les résultats d'un projet de recherche. Les résumés de poster doivent être entrés sous "Abstract" et non "Poster".
Collection
Publications
Institution
Titre
First stereotactic treatment of retino-blastoma using a micro-multileaf collimator
Titre de la conférence
9th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO)
Adresse
Basel, Switzerland, March 17-19, 2005
ISBN
0179-7158
Statut éditorial
Publié
Date de publication
2005
Peer-reviewed
Oui
Volume
181
Série
Strahlentherapie und Onkologie
Pages
136
Langue
anglais
Résumé
Objective: To report the first stereotactic treatment of retinoblastoma using a micro-multileaf (mMLC) collimator.
Material and Methods: A standard mask used for fractionated stereotactic treatment was modified for the treatment of bilateral
retinoblastoma by adding an eye immobilisation device to the mask support. Stereotactic mMLC and
conventional (opposed lateral beams) treatment plans were compared using treatment planning based
dose volume histograms. The first patient was treated in November 2004.
Results: Stereotactic treatment using noncoplanar, mMLC shaped beams reduces dose to the ipsilateral organs at
risk and spares the contralateral organs at risk. The immobilisation device developed for the eye provides
precise positioning and was well tolerated by the patient.
Conclusion: Lateral irradiation techniques for bilateral retinoblastoma are frequently followed by complications.
Stereotactic irradiation using a mMLC is a feasible and promising alternative to conventional treatment
that does not require the fabrication of special collimators.
Material and Methods: A standard mask used for fractionated stereotactic treatment was modified for the treatment of bilateral
retinoblastoma by adding an eye immobilisation device to the mask support. Stereotactic mMLC and
conventional (opposed lateral beams) treatment plans were compared using treatment planning based
dose volume histograms. The first patient was treated in November 2004.
Results: Stereotactic treatment using noncoplanar, mMLC shaped beams reduces dose to the ipsilateral organs at
risk and spares the contralateral organs at risk. The immobilisation device developed for the eye provides
precise positioning and was well tolerated by the patient.
Conclusion: Lateral irradiation techniques for bilateral retinoblastoma are frequently followed by complications.
Stereotactic irradiation using a mMLC is a feasible and promising alternative to conventional treatment
that does not require the fabrication of special collimators.
Web of science
Création de la notice
28/04/2008 11:35
Dernière modification de la notice
20/08/2019 15:32
Données d'usage
